Ad copy

A 58-Year-Old Woman Died in My Clinic Last Month. She'd Been on Levothyroxine for 16 Years. Her TSH Was "Perfect." She did everything right. I know — because I was the one who prescribed it. I've been an endocrinologist for 23 years. Board-certified. Published. I've taught residents, mentored fellows, and built my career on the principle that thyroid hormone replacement saves lives. And for 23 of those years, I have written levothyroxine prescriptions with the confidence of a physician who believed the science was settled. Synthroid. Levoxyl. Armour. Tirosint. I've prescribed every one of them. Thousands of times. I've looked patients in the eye and said: "This will get your levels where they need to be." I believed it. Completely. But when MY thyroid started failing and my internist handed me a prescription for the same drug I'd been writing for two decades — something broke open that I'd been sealing shut for years. I didn't fill it. Ten months later my Free T3 was in the upper third of the range. Antibodies dropped. Weight came down 26 pounds. Without levothyroxine. Without Armour. Without a single thyroid pharmaceutical. And what I used to do it is something that, as a physician, I am ashamed I didn't know about sooner. Because it explains every "I still feel terrible" conversation I've had with medicated patients across 23 years of endocrinology. If your doctor is pushing levothyroxine and you're looking for a reason to question whether that's enough — keep reading. If you're already on thyroid medication and the fatigue, the brain fog, the hair loss, and the weight gain are stealing your quality of life despite "normal" labs — keep reading. If you've tried selenium, ashwagandha, zinc, B12, gluten-free, AIP, and nothing holds for more than a few weeks — keep reading. Because after 23 years and thousands of patients, I finally understand why the drug I built my practice on fails the women who trust it most. And what I found instead has more clinical research behind it than most supplements in your medicine cabinet. I need to tell you about her. The woman from last month. Because until you understand what happened to her, nothing else I say will make sense. In endocrinology, you see the same story on repeat. But the cases that follow you home are the ones that shouldn't have happened. Linda. 58. Retired school administrator. Came into my clinic for what should have been a routine follow-up. She'd been my patient for sixteen years. I personally diagnosed her with Hashimoto's thyroiditis. My handwriting was on the original lab order. My signature on the first levothyroxine prescription. She'd come in with a TSH of 14.2 and textbook symptoms — fatigue, weight gain, hair thinning, cold intolerance. I'd sat across from her and said the words I'd said a thousand times before: "We'll get your levels stabilized. You're going to feel like yourself again." She'd smiled and said: "You're the doctor." Her most recent labs — eight weeks before the appointment — were textbook. TSH: 1.8. Right in the sweet spot. Numbers any endocrinologist in America would look at and say exactly what I would have said: "Perfect. Stay the course." But Linda didn't look perfect. Linda looked like she was dying. She'd gained 64 pounds since I first prescribed the medication. Sixty-four. Her face was so swollen she barely resembled the woman in her chart photo. Her hair — which had been thick and dark when I first met her — was thin, brittle, and visibly sparse under the exam room lights. She told me she'd stopped going to her book club because the brain fog was so bad she couldn't follow the discussion. Couldn't remember character names. Couldn't hold a thought through a paragraph. She told me she'd been to see a cardiologist three months earlier because her cholesterol kept climbing despite dietary changes. Her cardiovascular markers were deteriorating. The cardiologist put her on a statin and told her to follow up. She sat across from me — the same chair she'd sat in sixteen years ago — and said: "You told me I'd feel like myself again. I don't even remember what myself feels like." I adjusted her dose. Again. Ordered expanded labs — Free T3, Reverse T3, antibodies. Told her we'd regroup in six weeks. She had a stroke four weeks later. Her daughter called the office. Linda was in the ICU. Massive cerebrovascular event. The neurologist noted severe atherosclerotic disease — arterial walls that had been degrading for years. Cholesterol that had been climbing because her liver cells weren't getting the thyroid hormone they needed to metabolize it. A cardiovascular system that had been silently deteriorating for over a decade while her TSH sat perfectly in range. She didn't make it. Gone within 72 hours. I sat in my office after the call. Door closed. Her chart on my screen. My handwriting on the first page from sixteen years ago. The notes from our last visit where I'd adjusted her dose one more time and told her to come back in six weeks. And between those two entries, sixteen years of refills, dose adjustments, and notes that said "TSH within range — continue current regimen." All of it mine. I didn't think "the protocol failed." I thought: I failed her. That wasn't the first time I'd had that feeling. But it was the first time I let myself think it clearly. Over the past several years I'd been keeping a private count. Not officially — just in my head. Every follow-up where the patient was medicated, TSH was normal, and they were sitting across from me visibly suffering. Gaining weight. Losing hair. Foggy. Puffy. Exhausted. Cold. Depressed. I stopped counting after two years. There were too many. And every time I'd look at the labs and say some version of the same sentence: "Your levels are right where we want them. Give the medication time." After the thousandth time I said that sentence — to women who were doing everything I told them to do and getting worse — I realized something I did not want to be true. If the levels are right where we want them and the patient is still deteriorating — then maybe we're measuring the wrong thing. I kept that thought locked away. Not because I lacked the authority to raise it. I kept it locked away because if it was true, then every prescription I'd written, every patient I'd reassured, every resident I'd trained to check TSH and adjust the dose — twenty-three years of confident evidence-based decisions — all of it suddenly in question. That's not a thought you let yourself think on a Monday morning before a full clinic. So I didn't. Then last spring, at my annual physical, my bloodwork came back. TSH: 5.8. Elevated TPO antibodies. Early Hashimoto's. My internist — a good doctor, a woman I've known for twelve years — looked at me and said: "You know the protocol. Levothyroxine. 50 mcg. We'll recheck in eight weeks." She wrote the prescription. I took it. Drove home. That night I mentioned it to my husband. He's not in medicine — he's an engineer. But he'd watched me come home quiet after certain clinic days. He'd watched me sit in the car in the driveway before coming inside. He knew something had been building for years. "So take it," he said. "You prescribe it every day." I looked at the prescription on the counter. My internist's handwriting. The same drug class I'd prescribed to Linda sixteen years ago. The same drug I'd written for thousands of women. I put it in my jacket pocket. And I never filled it. Because I'd spent sixteen years watching Linda take it. Watching her gain 64 pounds. Watching her hair thin. Watching her brain fog thicken. Watching her cardiovascular system deteriorate. Watching her die of a stroke with a perfect TSH. I wasn't going to be Linda. Instead I did something I should have done years ago. I stopped trusting the protocol I'd built my career on — and started reading the research underneath it. What I found in three weeks made 23 years of clinical practice suddenly make sense. And it didn't make me angry. It made me sick. Because I wasn't reading about someone else's mistake. I was reading about my own. --- Here's what medical school taught me: The thyroid gland doesn't produce enough hormone. TSH rises. Prescribe replacement. TSH normalizes. Patient is treated. The logic is clean. The guidelines are clear. The prescription writes itself. I know — I've written it thousands of times. Here's what medical school didn't teach me. Levothyroxine delivers T4 into the bloodstream. T4 is inactive. It cannot run your metabolism, your energy, your temperature, your hair growth, or your weight in the form it arrives. About 60% of it must convert to active T3 inside the liver before a single cell can use it. The conversion happens inside the liver. In specific liver cells. Using a specific enzyme. And chronic cortisol elevation attacks that conversion at three simultaneous points — all inside the same liver tissue — all invisible to TSH. Three simultaneous failures: Checkpoint one. Cortisol deposits fat around the liver tissue that houses the conversion enzyme. Layer by layer. Cell by cell. Under chronic stress. The enzyme's physical environment degrades. The T4 arrives every morning and the tissue processing it is compromised. Conversion slows. Checkpoint two. Cortisol suppresses AMPK — the cellular ignition signal the enzyme needs to activate. The enzyme sits idle. It doesn't matter how much T4 arrives. It doesn't matter how much selenium you feed it. The ignition is off. You can fill an engine with the best fuel in the world. If the ignition is off it doesn't start. Checkpoint three. Cortisol overproduces reverse T3 — a decoy molecule structurally identical to active T3. It binds every thyroid receptor in the body. Does nothing once bound. The active T3 that does convert arrives at cells and finds every receptor already occupied by a molecule that looks like the key but opens nothing. And here's what I have to live with. Levothyroxine does not clear the blockade. Every prescription I have ever written does the same thing: delivers synthetic T4 into the bloodstream. The pituitary gland sees the T4, stops producing excess TSH, and the lab number normalizes. I look at the number and say "your levels are right where we want them." But the T4 in the bloodstream still has to convert to active T3 inside the liver before it can reach any cell. When cortisol has deposited fat around the conversion enzyme, suppressed its ignition, and flooded every receptor with a decoy — the T4 enters the blood and cannot complete its conversion. The labs improve. The delivery fails. The patient deteriorates. That's why Linda died with perfect numbers and a failing body. The levothyroxine I prescribed sixteen years ago did exactly what it was designed to do. It normalized the number. And the number was never the real problem. The real problem was the cortisol running three simultaneous conversion blockades inside her liver — all invisible to the measurement point everyone was watching. And it gets worse. Because the drug I've been prescribing for 23 years isn't just failing to address the root cause — it's masking a deterioration I've been documenting in my patients without understanding. When T4 cannot efficiently convert and reach cells, the body begins shunting T4 into reverse T3. An inactive molecule that's structurally identical to active T3 but does the exact opposite. It binds to T3 receptors. Blocks them. Occupies them without activating them. So the blockade isn't just preventing T3 delivery — it's causing the body to produce a molecule that actively prevents whatever T3 IS available from doing its job. More medication. More T4 in the blood. More reverse T3 production. More receptor blockade. More weight gain. More fatigue. More hair loss. More cognitive decline. The TSH looks beautiful. The patient is falling apart. I have looked at "normal" TSH results and said "your medication is working" to women who were gaining weight, losing hair, losing cognitive function, and developing cardiovascular disease — for twenty-three years. I was the one deciding the medication was working. I was the one telling them to stay the course. I was the one charting "TSH within range — continue current regimen" while the conversion cascade that determines whether any of it reaches their cells was completely blocked. Not once in 23 years did I assess cortisol's effect on liver conversion capacity. Not once did I order a reverse T3 alongside a free T3. Not once did I ask: is the T4 I'm prescribing actually converting — or is it being shunted into a decoy that's occupying every receptor? Not once. And I'm the one who prescribed it. The weight gain. I've heard it from hundreds of patients. "I eat 1,200 calories a day and gain weight." "I exercise five days a week and the scale won't move." I documented those complaints. I wrote "continue current dose — weight management counseling recommended" more times than I want to admit. I was recommending diet counseling to women whose fat cells were locked on a storage default because active T3 was never reaching them — because cortisol had blocked the conversion at three simultaneous points inside the liver. The hair loss. Women crying in my exam room holding clumps of hair. I'd check their TSH, see a normal number, and say "it might be stress." I charted "telogen effluvium — likely multifactorial." I never once wrote: "Consider that the conversion enzyme is idle because cortisol has suppressed its ignition signal." The brain fog. Patients who were sharp becoming confused. Forgetting words. Losing their train of thought mid-sentence. I referred them to neurology. I charted "cognitive changes — evaluate for early dementia." I never once — not once in 23 years — wrote: "Consider that active T3 is not reaching brain cells because reverse T3 has occupied every receptor." Not once. And I was the one they trusted. And here's what made me sickest of all. The connection between chronic cortisol elevation and T4-to-T3 conversion failure is in the endocrinology literature. The role of cortisol in hepatic fat accumulation and its downstream effect on the deiodinase enzyme is documented. The reverse T3 mechanism and its relationship to cortisol excess has been published and replicated for decades. The AMPK suppression pathway connecting cortisol to conversion failure exists in peer-reviewed research I have cited throughout my career. But the clinical protocol for hypothyroid weight gain that doesn't respond to levothyroxine doesn't include a cortisol assessment. Doesn't measure reverse T3. Doesn't evaluate liver conversion capacity. Doesn't ask whether chronic cortisol is running a three-checkpoint blockade that no dose increase will ever penetrate. Because there is no pharmaceutical drug for a cortisol-driven conversion blockade. You cannot patent the mechanism. There is no revenue in telling a patient that her stress hormones are blocking her medication from working inside her liver. There IS revenue in increasing the levothyroxine dose when it stops working. GLP-1 injections for weight gain that was never caloric. Specialist appointments every six months to check a TSH that was never measuring where the failure was happening. Manage the number. Never address the blockade. Keep the patient returning indefinitely. I had twenty-three years of reading this in journals and five minutes of reading my own labs to understand why it made me sick. --- The answer came from a colleague I hadn't spoken to in four years. Rachel and I trained together during fellowship. Brilliant endocrinologist — the kind of physician who made the rest of us feel like we were reading different textbooks. She left clinical practice about five years ago. Most of us assumed she'd burned out. I found out later she'd left because she'd seen the same pattern I'd been seeing — and decided to go chase the answer instead of charting the same failing protocol. I ran into her at an endocrinology conference in Boston last fall. Not planned. I was leaving a panel on thyroid dosing optimization — the kind where everyone agrees the current approach is working — and I saw her in the lobby, alone, reading a journal article with a coffee going cold beside her. We hadn't talked since her farewell dinner. But I sat down, and within ten minutes I was telling her about Linda. About the count I'd been keeping in my head. About the prescription I'd never filled. She set the journal down. Looked at me. And said something I will never forget. "You're not wrong. The replacement model is incomplete. And the thing that's missing — the thing that explains your symptomatic patients — is the cortisol-driven conversion blockade. You've been filling the river and ignoring the dam." We sat there for two hours. She walked me through the research. The literature on cortisol and hepatic fat accumulation. The studies on AMPK suppression and its downstream effect on the deiodinase enzyme. The reverse T3 mechanism and receptor blockade. Published in journals I've referenced for CME credits throughout my career. And the mechanism — when she laid it out — explained everything I'd seen in 23 years of patients who were medicated, "normal," and suffering. The T4 was in the blood. The conversion was blocked. The labs measured the blood. The labs said fine. The cells said starving. Every unexplainable "I still feel terrible" conversation. Every patient I'd told "your levels are right where we want them." Every dose adjustment that normalized a number and changed nothing in the body. All of it — explained by a single mechanism that nobody in my training ever mentioned. At some point that evening I asked her: "If you're not prescribing levothyroxine, what are you doing?" She pulled up her own lab results on her phone. Slid it across the table. Her Free T3 was in the upper third of the range. Antibodies were lower than they'd been in five years. Reverse T3 was negligible. Then she told me about a compound that specifically targets the cortisol-driven conversion blockade at all three checkpoints simultaneously — from inside the liver cells where the blockade lives. Not a thyroid support supplement. Not selenium. Not another attempt to increase supply into a blocked conversion pathway. A hepatocyte-level repair compound. Something that clears the fat cortisol has deposited around the conversion enzyme, reactivates the AMPK ignition cortisol suppressed, and quiets the inflammatory signal overproducing the reverse T3 decoy. "The thyroid isn't the bottleneck," she said. "The liver conversion blockade is the bottleneck. Clear the blockade and the hormone reaches the cells. It's that simple. And nobody is doing it because there's no pharmaceutical version." She told me about Liposomal NAD+ Complex. A liposomal hepatocyte-restoration formula built around the specific compounds that cross liver cell membranes and reach the cells running the blockade at concentrations that actually affect the mechanism. She walked me through the full formulation. Liposomal NMN at clinical concentration: restores NAD+ to hepatocyte mitochondria — the cellular fuel the conversion enzyme requires to run. Bypasses gastric destruction entirely. Delivers to liver cells at 13.6 times the concentration of standard NAD+ capsules. Without this, the conversion enzyme has no cellular energy even when the ignition signal returns. Checkpoint one — addressed at the source. Berberine 500mg: directly activates AMPK inside the hepatocyte — the exact cellular ignition signal cortisol had suppressed. The conversion enzyme sitting idle with plenty of T4 finally gets the activation signal it was waiting for. The ignition turns on. Checkpoint two — addressed at the source. KSM-66 Ashwagandha at clinical dose: root-only extract standardized to 5% withanolides. The specific form used in the clinical research showing up to 32% cortisol reduction. Directly addresses the upstream cortisol elevation driving all three checkpoints. Lower the cortisol and the blockade stops being reinforced every day. Liposomal CoQ10: stabilizes mitochondrial energy inside hepatocytes. Keeps the conversion enzyme functional even under residual oxidative stress. Resveratrol 200mg: activates the sirtuin pathway and suppresses TGF-β1 — the master inflammatory signal in liver tissue driving the cortisol cascade that overproduces reverse T3. When that signal normalizes, the decoy overproduction drops. The receptors start clearing. Active T3 starts landing. Checkpoint three — addressed at the source. Turmeric Extract at 95% curcuminoids: reduces the systemic inflammatory load that compounds hepatic dysfunction and accelerates the cortisol-driven conversion blockade. Third-party tested. Made in the USA. Every ingredient listed with exact doses. No proprietary blends. "The standard thyroid support supplements don't work," she said. "They feed the river. They don't open the dam. Selenium, zinc, B12 — they're cofactors for an enzyme that's been suppressed and surrounded by hepatic fat. You can't activate an enzyme cortisol has buried by giving it more cofactors. You have to clear the burial first." She told me about a company called Liposomal NAD+ Complex. Every specification from the research. Every dose listed. Third-party tested. No proprietary blends. I ordered it the night I got home from Boston. --- I didn't tell my husband. Didn't set expectations. Just added two capsules to my morning routine before leaving for the clinic. The first thing I noticed — within the first week — was the puffiness. My face had been subtly swollen for over a year. I'd blamed it on aging, on salt, on poor sleep. By day five, my jawline had definition I hadn't seen in months. By week two my brain came back. Not gradually — like someone turned the lights on. I was reviewing a patient's lab panel and cross-referenced three values in my head without reaching for the calculator. I hadn't been able to do that in over a year. I sat at my desk and registered the moment because I knew what it meant. The T3 was reaching my brain cells. By week three the fatigue shifted. Not stimulant energy. Not caffeine. The kind of energy where you realize you've been operating at 60% for so long that 60% felt normal. It wasn't normal. I was just used to it. I stepped on the scale at week four. Seven pounds down. Same food. Same activity. My body was responding to diet and exercise for the first time in over a year — because my cells were finally getting the thyroid hormone they needed to drive metabolism. The hair. Week five is when I noticed. The drain wasn't collecting clumps. I could run my fingers through without that sick feeling of strands pulling away. By week eight, my hairdresser commented on new growth at my temples. I ran my own bloodwork at ten months. Free T3: upper third of the range. Higher than it had been in my chart history. Reverse T3: dropped to negligible levels. TPO Antibodies: down significantly from initial diagnosis. TSH: settled to 2.1 — from 5.8 — without a single milligram of levothyroxine. I sat with those results for a long time. Because they confirmed what Rachel had told me in Boston. The thyroid wasn't the bottleneck. The cortisol-driven conversion blockade was the bottleneck. Once the blockade cleared, my own thyroid — which had been labeled as failing — was producing and delivering enough hormone on its own. I told two colleagues at the clinic. Quietly. Just showed them my labs and walked them through the mechanism. Within three months, three physicians in my practice were taking Liposomal NAD+ Complex. One of them — a 52-year-old internist who'd been on levothyroxine for seven years — added it alongside her medication. Within six weeks, her Free T3 was higher than it had been since she started treatment. She came into my office with her labs and said: "I forgot what it felt like to think clearly. I've been prescribing thyroid medication for twenty years and I never once considered what cortisol was doing to the conversion inside the liver." Another — a 38-year-old OB-GYN. Diagnosed with Hashimoto's during her second pregnancy. On Synthroid for four years. Still losing hair. Still exhausted. Still puffy. She added Liposomal NAD+ Complex. Eight weeks later she texted me a photo of her shower drain. "Look," she wrote. "Nothing in it. First time in four years." I'm not telling them to stop their medications. That's not my recommendation and that's not what I did. I'm telling you what I saw. What I experienced. What the research supports. --- Then I had to tell my husband. This is the part I've been avoiding writing. Because it wasn't a medical conversation. It was a marriage conversation. I printed the labs. Waited until Sunday morning. He was at the kitchen table with his coffee and his crossword — he does the Sunday crossword in pen, every week, never misses. I sat down across from him and put the printout between his puzzle and his mug. He read it. He's an engineer — he reads data quickly, even medical data. Ten seconds. He looked up. "You never filled it." Not a question. A statement. "No." He set down his pen. And he didn't say anything for what felt like a very long time. I told him everything. The cortisol mechanism. The three checkpoints. The AMPK ignition. The reverse T3 flooding the receptors. Rachel and what she'd shown me at the conference. I talked for twenty minutes. He didn't interrupt once. When I finished, he picked up his coffee. Took a sip. It was cold. He drank it anyway. Then he said: "You're the doctor. But next time, tell me." That was it. Because he's an engineer. Data is data. The numbers moved. The mechanism made sense. He didn't need to be convinced. He needed to be informed. Two weeks later he brought up something I hadn't expected. "My mother," he said. "She's been on Synthroid for nine years. She's miserable. Can we send her a bottle?" We did. She called six weeks later. Crying. "I can think again," she said. "I forgot what it felt like to think clearly." --- I think about Linda sometimes. Levothyroxine for sixteen years. Perfect TSH. My handwriting on her chart. Dead of a stroke while the medication I prescribed sat in her blood and her cortisol ran three simultaneous conversion blockades that I never once tested for. I think about all the patients I prescribed thyroid medication to and sent home with confidence. All the TSH results I looked at and smiled at. All the times I said "Your levels look great — stay the course." I think about the residents I trained. The ones who stood beside me while I checked TSH and adjusted doses and learned to do the same thing. I didn't just prescribe — I taught others to prescribe. If I was wrong, the damage didn't stop with my patients. I used to say "I don't understand why you still feel this way." I understand now. And understanding is worse. Because understanding means I know what I didn't do. What I could have done. What I should have been looking for all along. The TSH was fine. The cortisol was running three simultaneous blockades inside the liver. And the hormone I prescribed was piling up in the bloodstream, never completing its conversion, while I smiled at a lab number that measured the wrong thing. If you're on thyroid medication right now and wondering whether it's actually converting — I hear you. I've spent 23 years watching the answer to that question play out in my clinic. If your doctor keeps increasing your dose and you keep feeling the same — I hear you. I was the doctor doing that. If you've tried everything — selenium, ashwagandha, zinc, B12, gluten-free, AIP — and nothing holds — I hear you. Because nothing you tried was clearing the conversion blockade at the three points where cortisol has it locked. --- Liposomal NAD+ Complex. Liposomal NMN at clinical concentration — the form that actually reaches hepatocyte mitochondria and restores the cellular energy the conversion enzyme requires. Berberine 500mg reactivating the AMPK ignition cortisol suppressed. KSM-66 Ashwagandha at clinical dose addressing the upstream cortisol driving the blockade. Liposomal CoQ10 for mitochondrial stability inside liver cells. Resveratrol 200mg suppressing the inflammatory signal overproducing the reverse T3 decoy. Turmeric at 95% curcuminoids for inflammatory load reduction. I've spent my career trusting peer-reviewed evidence over anecdote. I'm not writing this because I sell Liposomal NAD+ Complex — I don't. I'm writing this because the mechanism changed my understanding of the disease I've treated for 23 years. And if it can change the mind of an endocrinologist who prescribed levothyroxine for two decades, it deserves to be seen by the women taking it. Third-party tested. Made in the USA. Clinical doses of all compounds. Every dose listed on the label. No proprietary blends. 60-day money-back guarantee. 👉 https://tryboostiva.shop/products/liposomal-nad-for-men-1 --- P.S. Three physicians in my practice are now taking Liposomal NAD+ Complex. I didn't recruit them. I didn't sell it. I showed them my labs and walked them through the mechanism. Endocrinologists understand hepatic conversion anatomy — we studied liver enzyme pathways in training and then somehow never applied them to what happens to levothyroxine after it enters the bloodstream. When you show a physician the cortisol-conversion mechanism, they don't need convincing. They need the data. These are doctors who've been prescribing thyroid medication for decades and watching patients suffer despite "perfect" numbers — and every one of them noticed the difference within the first two weeks. P.P.S. In 23 years of endocrinology, I've prescribed medications that take six to eight weeks to show any measurable effect and patients just have to trust the process. Liposomal NAD+ Complex is the first thing I've ever taken where I felt the mechanism working within the first week. The puffiness reduction by day five. The cognitive clarity by week two. That's the conversion blockade clearing and T3 reaching cells it hasn't reached in years. If you've taken thyroid supplements before and felt nothing, that's because they were adding more supply into a blocked conversion pathway. This clears the blockade. You'll know the difference. P.P.P.S. Liposomal NAD+ Complex has a 60-day money-back guarantee. If you don't feel the difference, full refund. No questions asked. I have never once in my career seen a pharmaceutical company offer to return your money if their drug didn't perform. Not once. Consider what that tells you about who stands behind their product and who doesn't. P.P.P.P.S. Liposomal NAD+ Complex is produced in clinical-grade batches with third-party testing at every run. They sell out. If you have bloodwork coming up in the next 30 to 60 days and you want to give the conversion pathway a real chance at better numbers before that draw, check availability now. Don't wait. Every day the cortisol blockade runs is another day of T4 piling up in the bloodstream while your cells starve — and another day closer to the dose adjustment your doctor is already planning. P.P.P.P.P.S. Do not forget about the 60-day money-back guarantee. 👉 https://tryboostiva.shop/products/liposomal-nad-for-men-1